BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21944286)

  • 21. Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.
    Manerba M; Vettraino M; Fiume L; Di Stefano G; Sartini A; Giacomini E; Buonfiglio R; Roberti M; Recanatini M
    ChemMedChem; 2012 Feb; 7(2):311-7. PubMed ID: 22052811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
    Lu NN; Weng ZY; Chen QY; Boison D; Xiao XX; Gao J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():21-25. PubMed ID: 27104676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors.
    Galal SA; Hegab KH; Hashem AM; Youssef NS
    Eur J Med Chem; 2010 Dec; 45(12):5685-91. PubMed ID: 20884089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of 1-(4'-Indolyl and 6'-Quinolinyl) indoles as a new class of potent anticancer agents.
    Lai MJ; Chang JY; Lee HY; Kuo CC; Lin MH; Hsieh HP; Chang CY; Wu JS; Wu SY; Shey KS; Liou JP
    Eur J Med Chem; 2011 Sep; 46(9):3623-9. PubMed ID: 21641700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
    J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin.
    Mahale S; Aubry C; Jenkins PR; Maréchal JD; Sutcliffe MJ; Chaudhuri B
    Bioorg Chem; 2006 Oct; 34(5):287-97. PubMed ID: 16904725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines.
    Libnow S; Methling K; Hein M; Michalik D; Harms M; Wende K; Flemming A; Köckerling M; Reinke H; Bednarski PJ; Lalk M; Langer P
    Bioorg Med Chem; 2008 May; 16(10):5570-83. PubMed ID: 18434163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural influence of indole C5-N-substitutents on the cytotoxicity of seco-duocarmycin analogs.
    Choi T; Ma E
    Arch Pharm Res; 2011 Mar; 34(3):357-67. PubMed ID: 21547666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.
    Calvaresi EC; Granchi C; Tuccinardi T; Di Bussolo V; Huigens RW; Lee HY; Palchaudhuri R; Macchia M; Martinelli A; Minutolo F; Hergenrother PJ
    Chembiochem; 2013 Nov; 14(17):2263-7. PubMed ID: 24174263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
    Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An expeditious synthesis and anticancer activity of novel 4-(3'-indolyl)oxazoles.
    Kumar D; Kumar NM; Sundaree S; Johnson EO; Shah K
    Eur J Med Chem; 2010 Mar; 45(3):1244-9. PubMed ID: 20047778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
    Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
    J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and antiproliferative activity of novel aminosubstituted benzothiopyranoisoindoles.
    Christodoulou A; Kostakis IK; Kourafalos V; Pouli N; Marakos P; Trougakos IP; Tsitsilonis OE
    Bioorg Med Chem Lett; 2011 May; 21(10):3110-2. PubMed ID: 21444205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-molecule inhibitors of human LDH5.
    Granchi C; Paterni I; Rani R; Minutolo F
    Future Med Chem; 2013 Oct; 5(16):1967-91. PubMed ID: 24175747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
    Bindi S; Fancelli D; Alli C; Berta D; Bertrand JA; Cameron AD; Cappella P; Carpinelli P; Cervi G; Croci V; D'Anello M; Forte B; Giorgini ML; Marsiglio A; Moll J; Pesenti E; Pittalà V; Pulici M; Riccardi-Sirtori F; Roletto F; Soncini C; Storici P; Varasi M; Volpi D; Zugnoni P; Vianello P
    Bioorg Med Chem; 2010 Oct; 18(19):7113-20. PubMed ID: 20817473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence.
    Hanessian S; Auzzas L; Giannini G; Marzi M; Cabri W; Barbarino M; Vesci L; Pisano C
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6261-5. PubMed ID: 17892933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents.
    You H; Youn HS; Im I; Bae MH; Lee SK; Ko H; Eom SH; Kim YC
    Eur J Med Chem; 2011 Apr; 46(4):1153-64. PubMed ID: 21330015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.
    Lee S; Shinji C; Ogura K; Shimizu M; Maeda S; Sato M; Yoshida M; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4895-900. PubMed ID: 17588744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C6-(N,N-butyl-methyl-heptanamide) derivatives of estrone and estradiol as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: Chemical synthesis and biological evaluation.
    Cadot C; Laplante Y; Kamal F; Luu-The V; Poirier D
    Bioorg Med Chem; 2007 Jan; 15(2):714-26. PubMed ID: 17110114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors.
    Benelkebir H; Hodgkinson C; Duriez PJ; Hayden AL; Bulleid RA; Crabb SJ; Packham G; Ganesan A
    Bioorg Med Chem; 2011 Jun; 19(12):3709-16. PubMed ID: 21382717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.